Radiology Business Management Association Technology Task Force. Sample Request for Proposal



Similar documents
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary.

Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene

2012 Physician Quality Reporting System:

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Orchard Software Webinar August 19, Slide 1

Stage 2 June 13, 2014

An Introduction to the Medicare EHR Incentive Program for Eligible Professionals

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Overview.

Overview of Clinical Quality Measures Reporting in the Centers for Medicare & Medicaid Services (CMS) Final Rule on Meaningful Use

Medicare & Medicaid EHR Incentive Program Specifics of the Program for Eligible Professionals. August 10, 2010

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method

Meaningful Use. Relevance. What is ARRA Meaningful Use? (American Recovery and Reinvestment Act of 2009)

Test Procedure for (j) Calculate and Submit Clinical Quality Measures

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION

Clinical Quality Measures. for 2014

Primary Care in the U.S. Measuring and Improving Primary Care in the United States ISQua Indicators Summit CMS Measures. Primary Care Measures

2013 ACO Quality Measures

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

InteGreat EHR Meaningful Use 2 Features and Reports Jenni Walters, Sr. Business Analyst, McKesson Beth Crews, Business Analyst, McKesson

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

ABELMed EHR-EMR/PM version 12, an ONC HIT 2014 Edition Complete EHR, has been certified for the following 42 clinical quality measures (CQMs).

Tuesday, May 6, :00 Noon EDT Dial In: Meeting ID: No audio available through Webinar

Meaningful Use - The Basics

0 What is Meaningful Use and where are we? 0 What is the Physician Quality Reporting System and where stage are we on?

Allscripts CQS Planning for 2014 Webinar: FAQs

Price Transparency Attestation emr4md version /03/2014

Meaningful Use - Stage 1. And. Practice Maximus

Meaningful Use Guidelines: Radiologists

Ophthalmology Meaningful Use Attestation Guide Stage Edition

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015

How To Improve Health Care Through A Health Care System

ACO Program: Quality Reporting Requirements. Jennifer Faerberg Mary Wheatley April 28, 2011

Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012

11/2/2015 Domain: Care Coordination / Patient Safety

VIII. Dentist Crosswalk

Meaningful Use Stage 1:

Meaningful Use Objectives

Stage 1 vs. Stage 2 Comparison for Eligible Professionals

ACO Name and Location Allina Health Minneapolis, Minnesota

Chapter Three Accountable Care Organizations

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

Meaningful Use Qualification Plan

Primary Care Quality Care Indicators - Accuro EMR Prevention

Welcome The AAMC, UHC and FPSC Web Conference on 2014 PQRS Proposed Changes will begin shortly.

E Z BIS ELECTRONIC HEALTH RECORDS

Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012

Dashboard Overview Webinar

Contact: Barbara J Stout RN, BSC Implementation Specialist University of Kentucky Regional Extension Center

Achieving Meaningful Use with Centricity EMR

Comprehensive Primary Care (CPC) Assessment

Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2

EMR Name/ Model. meridianemr 4.2 CCHIT 2011 certified

AAP Meaningful Use: Certified EHR Technology Criteria

Meaningful Use Stage 2: Important Implications for Pediatrics

Meaningful Use Stage 2 Implementation Guide

ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS

Where to Begin? Auditing the Current EHR System

Manitoba EMR Data Extract Specifications

EMR Name/ Model. Cerner PowerChart Ambulatory (PowerWorks ASP)

Meaningful Use Stage 2. Presenter: Linda Wise, EMR Training Specialist

Meaningful Use Cheat Sheet CORE MEASURES: ALL REQUIRED # Measure Exclusions How to Meet in WEBeDoctor

CQMs. Clinical Quality Measures 101

Transcription:

Technology Task Force Sample Request for Proposal This document has been created by the RBMA s Technology Task Force as a guideline for use by RBMA members working with potential suppliers of Electronic Health Records Technology certified to meet Meaningful Use requirements for Radiologists 1. Company Background and History Provide general company information, and also provide specific answers to the following questions: 1.1 Who owns your company? If your company is publicly traded, who are the major investors? 1.2 Has your company been subject to a buyout or has it purchased another company at any time? If yes, please provide details. 1.3 List the corporate officers and their titles. 1.4 Describe your company s primary business and your largest customer base (e.g. hospitals, multi-specialty groups, primary care physicians, specific medical specialists such as radiologists.) 1.5 Please provide corporate summary financial information for the past three years. 1.6 Please discuss your corporate mission and strategy with respect to ongoing EHR certifications and product development. 2. Products 2.1 What products does your company provide that are certified by the Office of the National Coordinator - Authorized Testing and Certification Body (ONC-ATCB), in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services (HHS)? 2.2 Describe the type of certified products your company provides (e.g. non-specialty specific Electronic Health Record, specialty specific Electronic Health Record, Radiology Information System, Picture Archiving and Communications System, Sample Request for Proposal Meaningful Use Technology 1

Hospital Information System, etc.). Also provide the name of the product(s) that have been certified, and the certification number(s). 2.3 Are your certified products certified as complete EHRs or EHR modules? 2.4 If you do not have a certified, complete EHR, does your company have an alliance with other companies to provide complete EHR solutions for radiologists? Please elaborate. 2.5 Are your products able to work with both the Medicare and Medicaid EHR incentive programs? 2.6 List each criterion that has been met which supports HHS s meaningful use objectives and measures. (Please complete the attached checklist beginning on page 4 of this RFP) 2.7 For which clinical quality measures ( CQMs ) have you certified? (Please complete the attached checklist beginning on page 4 of this RFP) 2.8 For which of the following settings are your company s products designed? 2.8.1 Hospital-affiliated radiologists who practice only in a hospital setting and who do not own an imaging center. Is your certified product a discrete technology purchased/licensed by radiologists, or is it an Ambulatory module within a hospital information system? If a discrete technology, describe how your certified product gathers the data from the hospital(s) necessary for MU reporting by hospital-based radiologists. If an Ambulatory module within a hospital information system, describe how your certified product provides the data necessary for MU reporting by hospital-based radiologists. Name any specific and/or preferred systems within the hospital information systems environment with which your certified product interacts. 2.8.2 Radiologists based solely at one or more Freestanding Imaging Centers. Is your certified product a RIS or a PACS? 2.8.3 A hybrid group which is both hospital-affiliated and either provides services at or owns a freestanding imaging center? Sample Request for Proposal Meaningful Use Technology 2

2.9 If hospital-based radiologists use your certified product, are they required to use any other specific technology, products or services? (For example, a hospital s Radiology Information System, PACS, or the billing/practice management function within a hospital information system)? 2.10 Please describe your software interoperability and interface capabilities. 2.11 Please describe your organization s approach to and experience with interfaces with other systems. 2.11.1 Are there systems with which you have particular success creating interfaces? 2.11.2 Are there systems with which you have had particular difficulty creating interfaces? 2.11.3 Have you had success interfacing with other 3rd party integrated EMRs? If so, please list. 2.12 Is your product available as: Software as a Service ( cloud-based )? Remote Hosted? On-site server? 3. Pricing 3.1 Describe your pricing model, including all options. 3.2 What will your product cost an individual radiologist? Provide information including up-front licensing, training, support, costs for data capture and reporting, any costs incurred by Stage 2 and Stage 3 requirements, and any other costs. Are there any volume discounts? Will there be any ongoing annual cost after the initial investment? 3.3 Describe any staffing or monitoring requirements. 3.4 Does your company guarantee that your product will meet all certifications and other requirements such that radiologists using your product can expect to qualify for full EHR incentive payments, presuming the appropriate data is gathered and submitted by the October 1 st, 2012 deadline? Sample Request for Proposal Meaningful Use Technology 3

4 Customer Information 4.1 How many radiologists currently use your certified products? 4.2 Provide names of clients who have successfully implemented your certified products. Please identify which if any have secured payments under the EHR Incentive Program. 5 Expectations 5.1 What resources would you anticipate adding to your company to accommodate our business? 5.2 What resources do you envision this radiology group would need to add to accommodate the use and maintenance of your products? 5.3 What training do you provide to the radiologists and their staff prior to go live? 5.4 What continuing training is available to the radiologists as their practice evolves, e.g. new members/staff, changes in the EHR incentive program? 5.5 What timeframe would you anticipate from date of contract signing to go live with your company? Explain. 5.6 What are the two biggest challenges your company faces as a provider of certified EHR products? 5.7 What do you envision will be the biggest challenge to your company in bringing your system live with this radiology group? 6 Other 6.1 What differentiates your certified product from those of your competitors? 6.2 Do you visit your customers and/or their facilities during the contract period? Sample Request for Proposal Meaningful Use Technology 4

Meaningful Use Checklist Please complete a separate checklist for each certified product Product Name: Certification Number: Core Set Criteria 1. Use CPOE for medication orders 2. Implement drug drug and drug allergy interaction checks 3. Generate and transmit permissible prescriptions electronically (erx) 4. Record demographics 5. Maintain an up to date problem list of current and active diagnoses 6. Maintain active medication list 7. Maintain active medication allergy list 8. Record and chart changes in vital signs: height, weight, blood pressure, calculate and display BM, plot and display growth charts for children 2 20 years, including BMI 9. Record smoking status for patients 13 years old or older 10. Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance with that rule 11. Report ambulatory clinical quality measures to CMS or the States 12. Provide patients with an electronic copy of their health information 13. Provide clinical summaries for patients for each office visit 14. Capability to exchange key clinical information 15. Protect electronic health information created or maintained by the certified EHR technology through the implementation of appropriate technical capabilities AVAILABLE IN PROCESS NOT AVAILABLE Menu Set Criteria 1. Implement drug formulary checks 2. Incorporate clinical lab test results into certified EHR technology as structured data 3. Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach Sample Request for Proposal Meaningful Use Technology 5

4. Send reminders to patients per patient preference for preventive/ follow up care 5. Provide patients with timely electronic access to their health information 6. Use certified EHR technology to identify patient specific education resources and provide those resources to the patient if appropriate 7. Perform medication reconciliation if patient is received from another setting or provider of care 8. Provide summary of care record for each transition of care or referral 9. Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission in accordance with applicable law and practice 10. Capability to submit electronic syndromic surveillance data to public health agencies and actual submission in accordance with applicable law and practice Clinical Quality Measures Core Set 1. Hypertension: Blood Pressure Measurement 2. Preventive Care and Screening Measure Pair: a) Tobacco Use Assessment, b) Tobacco Cessation Intervention 3. Adult Weight Screening and Follow up Alternate Core Set 1. Weight Assessment and Counseling for Children and Adolescents 2. Preventive Care and Screening: Influenza Immunization for Patients 50 years old or older 3. Childhood Immunization Status Additional Set 1. Diabetes: Hemoglobin A1c Poor Control 2. Diabetes: Low Density Lipoprotein (LDL) Management and Control 3. Diabetes: Blood Pressure Management 4. Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) 5. Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) 6. Pneumonia Vaccination Status for Older Adults 7. Breast Cancer Screening 8. Colorectal Cancer Screening Sample Request for Proposal Meaningful Use Technology 6

9. Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD 10. Heart Failure (HF): Beta Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 11. Anti depressant medication management: (a) Effective Acute Phase Treatment, (b)effective Continuation Phase Treatment 12. Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation 13. Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy 14. Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care 15. Asthma Pharmacologic Therapy 16. Asthma Assessment 17. Appropriate Testing for Children with Pharyngitis 18. Oncology Breast Cancer: Hormonal Therapy for Stage IC IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer 19. Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients 20. Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients 21. Smoking and Tobacco Use Cessation, Medical Assistance: a) Advising Smokers and Tobacco Users to Quit, b) Discussing Smoking and Tobacco Use Cessation Medications, c) Discussing Smoking and Tobacco Use Cessation Strategies 22. Diabetes: Eye Exam 23. Diabetes: Urine Screening 24. Diabetes: Foot Exam 25. Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL Cholesterol 26. Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation 27. Ischemic Vascular Disease (IVD): Blood Pressure Management 28. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 29. Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: a) Initiation, b) Engagement 30. Prenatal Care: Screening for Human Immunodeficiency Virus (HIV) Sample Request for Proposal Meaningful Use Technology 7

31. Prenatal Care: Anti D Immune Globulin 32. Controlling High Blood Pressure 33. Cervical Cancer Screening 34. Chlamydia Screening for Women 35. Use of Appropriate Medications for Asthma 36. Low Back Pain: Use of Imaging Studies 37. Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control 38. Diabetes: Hemoglobin A1c Control (<8.0%) Sample Request for Proposal Meaningful Use Technology 8